These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22509503)

  • 21. The pathogenesis of multiple sclerosis. The Bradshaw lecture 1986.
    McDonald WI
    J R Coll Physicians Lond; 1987 Oct; 21(4):287-94. PubMed ID: 3316624
    [No Abstract]   [Full Text] [Related]  

  • 22. [State of measles immunity in mulitple sclerosis].
    Atanadze SN
    Vopr Virusol; 1978; (3):259-67. PubMed ID: 695518
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathology and etiology in multiple sclerosis: a review.
    Kraft AM; Wessman HC
    Phys Ther; 1974 Jul; 54(7):716-20. PubMed ID: 4608763
    [No Abstract]   [Full Text] [Related]  

  • 24. The mystery of the origin of multiple sclerosis.
    McDonald WI
    J Neurol Neurosurg Psychiatry; 1986 Feb; 49(2):113-23. PubMed ID: 2936869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis and air pollution exposure: Mechanisms toward brain autoimmunity.
    Esmaeil Mousavi S; Heydarpour P; Reis J; Amiri M; Sahraian MA
    Med Hypotheses; 2017 Mar; 100():23-30. PubMed ID: 28236843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aetiology of MS-genetic aspects.
    Hauge M
    Acta Neurol Scand Suppl; 1977; 63():49-53. PubMed ID: 265670
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple sclerosis.
    Miller E
    Adv Exp Med Biol; 2012; 724():222-38. PubMed ID: 22411246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The possible underlying pathophysiological mechanisms for development of multiple sclerosis in familial Mediterranean fever.
    Alpayci M; Bozan N; Erdem S; Gunes M; Erden M
    Med Hypotheses; 2012 Jun; 78(6):717-20. PubMed ID: 22406096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunogenetics of multiple sclerosis].
    Clanet M; Cambon-Thomsen A; Rascol A
    Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical trauma and multiple sclerosis.
    Sibley WA
    Neurology; 1993 Oct; 43(10):1871-4. PubMed ID: 8413939
    [No Abstract]   [Full Text] [Related]  

  • 31. A review of the aetiology of multiple sclerosis: an ecological approach.
    Murrell TG; Harbige LS; Robinson IC
    Ann Hum Biol; 1991; 18(2):95-112. PubMed ID: 2024951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the possibility of preventing multiple sclerosis.
    Marcinkowski T
    Med Hypotheses; 1998 Nov; 51(5):445-6. PubMed ID: 9848477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperbaric oxygen therapy and multiple sclerosis.
    Perrins DJ; James PB
    Undersea Hyperb Med; 2002; 29(4):236-8; discussion 238-41. PubMed ID: 12797664
    [No Abstract]   [Full Text] [Related]  

  • 35. The complex genetic aetiology of multiple sclerosis.
    Oksenberg JR; Barcellos LF
    J Neurovirol; 2000 May; 6 Suppl 2():S10-4. PubMed ID: 10871777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier changes in multiple sclerosis.
    Trojano M; Manzari C; Livrea P
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):55-64. PubMed ID: 1345741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GM-CSF promotes migration of human monocytes across the blood brain barrier.
    Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
    Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of multiple sclerosis: where are we? Where should we go?
    Martin R; Stürzebecher CS; McFarland HF
    Nat Immunol; 2001 Sep; 2(9):785-8. PubMed ID: 11526386
    [No Abstract]   [Full Text] [Related]  

  • 39. EGFL7 - a potential therapeutic target for multiple sclerosis?
    Uphaus T; Zipp F; Larochelle C
    Expert Opin Ther Targets; 2018 Nov; 22(11):899-902. PubMed ID: 30312112
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunological mechanisms involved in the pathogenesis of multiple sclerosis].
    Correale J
    Rev Neurol; 2000 Sep 1-15; 31(5):471-6. PubMed ID: 11027101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.